NexImmune, Inc.
NEXI
$0.0001
$0.000.00%
| Weiss Ratings | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.95 | |||
| Price History | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -99.90% | |||
| 60-Day Total Return | -99.97% | |||
| 90-Day Total Return | -99.95% | |||
| Year to Date Total Return | -99.92% | |||
| 1-Year Total Return | -100.00% | |||
| 2-Year Total Return | -100.00% | |||
| 3-Year Total Return | -100.00% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -100.00% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $7.05 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Feb 28, 2025 | |||
| 52-Week High Price (Date) | Jul 11, 2024 | |||
| Valuation | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 139.00 | |||
| Enterprise Value | -2.42M | |||
| Price/Earnings (TTM) | 0.00 | |||
| Earnings Per Share (TTM) | -18.59 | |||
| Earnings Per Share Growth | -61.02% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | 0.15 | |||
| Enterprise Value/EBIT | 0.14 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.38M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 301 825 9810 | |||
| Address | 9119 Gaither Road Gaithersburg, MD 20877 | |||
| Website | www.neximmune.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -72.70% | |||
| Return on Equity | -- | |||
| Income Statement | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -16.38M | |||
| EBIT (TTM) | -17.06M | |||
| Net Income (TTM) | -20.62M | |||
| Net Income Avl. to Common (TTM) | -20.62M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 69.25% | |||
| EPS Diluted (TTM) | -18.59 | |||
| EPS Diluted Growth (Q YOY) | 76.76% | |||
| Balance Sheet | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.42M | |||
| Cash Per Share (Q) | $1.76 | |||
| Total Current Assets (Q) | 3.13M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 696.40K | |||
| Current Ratio (Q) | 0.660 | |||
| Book Value Per Share (Q) | $0.50 | |||
| Total Assets (Q) | 5.86M | |||
| Total Current Liabilities (Q) | 4.74M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 5.17M | |||
| Total Common Equity (Q) | 696.40K | |||
| Cash Flow | NEXI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 569.40K | |||
| Cash from Financing (TTM) | 3.14M | |||
| Net Change in Cash (TTM) | -13.89M | |||
| Levered Free Cash Flow (TTM) | -7.10M | |||
| Cash from Operations (TTM) | -17.61M | |||
